Abstract
Poly(D,L-lactide-co-glycolide) nanoparticles (PLGA NPs) modified with chitosan (CS) have been used as carriers for epirubicin (EPB) to overcome multidrug resistance in an adriamycin-resistant human breast cancer cell line (MCF-7/ADM). EPB-loaded PLGA NPs were prepared using the solvent evaporation technique and then surface modified with CS according to the adsorption (ADCS NPs) and chemical binding methods (CBCS NPs). The EPB-loaded PLGA NPs were observed to be spherical in shape by scanning electron microscopy and their mean size was determined to be 214.4 ± 21.0 by laser light scattering. The size of the EPB-loaded PLGA NPs increased following the CS-surface modification, but the drug encapsulation efficiency was reduced from 84.1 ± 3.4 to 72.0 ± 3.5% for the ADCS NPs and to 70.1 ± 3.6% for the CBCS NPs. The rates of in vitro drug release from the CS-modified NP formulations were determined by dialysis with both systems showing a biphasic release pattern involving an initial rapid release followed by a very slow release after 24 h. Moreover, the results of cell experiments showed that the cellular uptake of the CS-modified NPs into the MCF-7/ADM cells had increased compared with the free EPB and EPB-loaded PLGA NP, whereas their inhibitory effects on cell viability were reduced. Taken together, these results demonstrate that CS-modified EPB-loaded PLGA NPs exhibit several advantages for sustained drug release and the enhancement of drug toxicity in drug-resistant tumor cells, indicating that NPs of this type could potentially be used as carriers for anticancer drugs.
Keywords: Anticancer activity, chitosan, epirubicin hydrochloride, modification, PLGA nanoparticles.
Current Nanoscience
Title:Chitosan Surface-Modified PLGA Nanoparticles: Preparation, Characterization, and Evaluation of their In Vitro Drug-Release Behaviors and Cytotoxicities
Volume: 10 Issue: 2
Author(s): Hong-li Chen, Yong-xue Wang, Ping Zhou, Rui Liu, Wen-bin Nan, Yin-song Wang, Yong-tao Liu, Yan Wang, Qing-qing Xiong, Hui-gen Feng and Qi-qing Zhang
Affiliation:
Keywords: Anticancer activity, chitosan, epirubicin hydrochloride, modification, PLGA nanoparticles.
Abstract: Poly(D,L-lactide-co-glycolide) nanoparticles (PLGA NPs) modified with chitosan (CS) have been used as carriers for epirubicin (EPB) to overcome multidrug resistance in an adriamycin-resistant human breast cancer cell line (MCF-7/ADM). EPB-loaded PLGA NPs were prepared using the solvent evaporation technique and then surface modified with CS according to the adsorption (ADCS NPs) and chemical binding methods (CBCS NPs). The EPB-loaded PLGA NPs were observed to be spherical in shape by scanning electron microscopy and their mean size was determined to be 214.4 ± 21.0 by laser light scattering. The size of the EPB-loaded PLGA NPs increased following the CS-surface modification, but the drug encapsulation efficiency was reduced from 84.1 ± 3.4 to 72.0 ± 3.5% for the ADCS NPs and to 70.1 ± 3.6% for the CBCS NPs. The rates of in vitro drug release from the CS-modified NP formulations were determined by dialysis with both systems showing a biphasic release pattern involving an initial rapid release followed by a very slow release after 24 h. Moreover, the results of cell experiments showed that the cellular uptake of the CS-modified NPs into the MCF-7/ADM cells had increased compared with the free EPB and EPB-loaded PLGA NP, whereas their inhibitory effects on cell viability were reduced. Taken together, these results demonstrate that CS-modified EPB-loaded PLGA NPs exhibit several advantages for sustained drug release and the enhancement of drug toxicity in drug-resistant tumor cells, indicating that NPs of this type could potentially be used as carriers for anticancer drugs.
Export Options
About this article
Cite this article as:
Chen Hong-li, Wang Yong-xue, Zhou Ping, Liu Rui, Nan Wen-bin, Wang Yin-song, Liu Yong-tao, Wang Yan, Xiong Qing-qing, Feng Hui-gen and Zhang Qi-qing, Chitosan Surface-Modified PLGA Nanoparticles: Preparation, Characterization, and Evaluation of their In Vitro Drug-Release Behaviors and Cytotoxicities, Current Nanoscience 2014; 10 (2) . https://dx.doi.org/10.2174/15734137113096660113
DOI https://dx.doi.org/10.2174/15734137113096660113 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Classification of Breast Carcinoma In Situ
Current Genomics Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Current Medicinal Chemistry Current and Potential Treatments for Cervical Cancer
Current Cancer Drug Targets Anti-cancer Effects of Curcumin on Head and Neck Cancers
Anti-Cancer Agents in Medicinal Chemistry MMPs in Ovarian Cancer as Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Cancer Chemoprevention Drug Targets
Current Drug Targets The Role of Thrombomodulin in Atherosclerosis: From Bench to Bedside
Cardiovascular & Hematological Agents in Medicinal Chemistry Antioxidants in Health, Disease and Aging
CNS & Neurological Disorders - Drug Targets Targeting c-MET/HGF Signaling Pathway in Upper Gastrointestinal Cancers: Rationale and Progress
Current Drug Targets Targeting Tumor Lymphangiogenesis: An Update
Current Medicinal Chemistry Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor
Current Respiratory Medicine Reviews Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Current Pharmaceutical Design Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate Cancer
Current Drug Targets New Molecules and Strategies in the Field of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Trichinella spiralis and Tumors: Cause, Coincidence or Treatment?
Anti-Cancer Agents in Medicinal Chemistry Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway
Current Cancer Drug Targets Molecular Pathways in the Progression of Hormone-Independent and Metastatic Prostate Cancer
Current Cancer Drug Targets Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology
Current Bioinformatics PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism